UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Research and development of mAb drugs in China: a look from policy perspectives Journal article
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019,Volume: 15,Issue: 11,Page: 2695-2705
Authors:  Rong Jiang;  Yuanyuan Sun;  Carolina Ung;  Xinyue Dong;  Xiangjun Kong;  Yuanjia Hu;  Rong Shao
Favorite  |  View/Download:77/0  |  Submit date:2020/03/12
r&d Support And Guidance Policy  Clinical Trial Policy  Drug Lag  Innovation Support System  Mab Drugs  Marketing Approval Policy  
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu;  Rong Shao
Favorite  |  View/Download:17/0  |  Submit date:2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network  
Pharmaceutical patent valuation based on empirical models Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 209-220
Authors:  Jingyun Ni;  Rong Shao;  Carolina Oi Lam Ung;  Yitao Wang;  Yuanjia Hu;  Yong Cai
Favorite  |  View/Download:13/0  |  Submit date:2019/01/14
Pharmaceutical Patents  Patent Value  Valuation  Echnological Factors  Commercial Factors  Legal Factors